NeoGenomics, Inc. (NEO)
9.44
+0.18
(+1.94%)
USD |
NASDAQ |
May 01, 16:00
9.62
+0.18
(+1.91%)
After-Hours: 20:00
NeoGenomics Market Cap : 1.229B for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| UnitedHealth Group, Inc. | 334.73B |
| ADMA Biologics, Inc. | 2.505B |
| Amphastar Pharmaceuticals, Inc. | 992.70M |
| Krystal Biotech, Inc. | 7.831B |
| Monte Rosa Therapeutics, Inc. | 1.504B |
Market Cap Related Metrics
| PS Ratio | 1.627 |
| PEG Ratio | -0.4606 |
| Price to Book Value | 1.483 |
| Price | 9.44 |
| Earnings Yield | -8.19% |
| PEGY Ratio | -0.4606 |